When there will never be a randomized controlled trial

Julia J. Scialla, Myles Wolf*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

10 Scopus citations

Abstract

There are many unanswered questions about how to manage secondary hyperparathyroidism and associated alterations in mineral metabolism in patients with end-stage renal disease. We provide commentary on an observational study by Komaba et al. that presents interesting new insights into the long-standing controversy related to the impact of parathyroidectomy on survival of hemodialysis patients.

Original languageEnglish (US)
Pages (from-to)220-222
Number of pages3
JournalKidney international
Volume88
Issue number2
DOIs
StatePublished - Aug 4 2015

Funding

Julia J. Scialla is supported by National Institutes of Health grant K23-DK095949. Myles Wolf is supported by National Institutes of Health grants R01-DK076116, R01-DK081374, R01-DK094796, K24-DK093723, and U01-DK099930.

ASJC Scopus subject areas

  • Nephrology

Fingerprint

Dive into the research topics of 'When there will never be a randomized controlled trial'. Together they form a unique fingerprint.

Cite this